Similar articles

• [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].

  Limmer S, Ittel TH, Wietholtz H. Limmer S, et al. Z Gastroenterol. 2003 Aug;41(8):719-28. doi: 10.1055/s-2003-41208. Z Gastroenterol. 2003. PMID: 12910426 Review. German.
• Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

  Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK. Lai KC, et al. Am J Med. 2005 Nov;118(11):1271-8. doi: 10.1016/j.amjmed.2005.04.031. Am J Med. 2005. PMID: 16271912 Clinical Trial.
• Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.

  Vergara M, Catalán M, Gisbert JP, Calvet X. Vergara M, et al. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1411-8. doi: 10.1111/j.1365-2036.2005.02444.x. Aliment Pharmacol Ther. 2005. PMID: 15948807 Review.
• [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].

  Lesur G. Lesur G. Gastroenterol Clin Biol. 2001 Jun-Jul;25(6-7):725-6. Gastroenterol Clin Biol. 2001. PMID: 11688500 French. No abstract available.
• Peptic ulcer disease today.

  Yuan Y, Padol IT, Hunt RH. Yuan Y, et al. Nat Clin Pract Gastroenterol Hepatol. 2006 Feb;3(2):80-9. doi: 10.1038/ncpgasthep0393. Nat Clin Pract Gastroenterol Hepatol. 2006. PMID: 16456574 Review.